Diabetic ketoacidosis treatment outcomes and associated factors among adult diabetic patients in Ethiopia: A systematic review and meta-analysis

IF 2.7 Metabolism open Pub Date : 2025-03-25 DOI:10.1016/j.metop.2025.100360
Tsegaamlak Kumelachew Derse , Desalegn Metiku Kidie , Addisu Simachew Asgai , Tadios lidetu , Moges Tadesse Abebe
{"title":"Diabetic ketoacidosis treatment outcomes and associated factors among adult diabetic patients in Ethiopia: A systematic review and meta-analysis","authors":"Tsegaamlak Kumelachew Derse ,&nbsp;Desalegn Metiku Kidie ,&nbsp;Addisu Simachew Asgai ,&nbsp;Tadios lidetu ,&nbsp;Moges Tadesse Abebe","doi":"10.1016/j.metop.2025.100360","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Diabetic ketoacidosis is a severe complication of diabetes that can threaten life and has a considerable effect on healthcare systems, especially in developing nations such as Ethiopia. Although it is clinically significant, comprehensive data on the factors that lead to unsatisfactory treatment outcomes in diabetic ketoacidosis patients in Ethiopia are lacking. This review aims to investigate and evaluate unsatisfactory treatment outcomes and multiple contributing factors related to diabetic ketoacidosis among patients with diabetes in Ethiopia. This review seeks to identify these factors to provide insights that can guide improvements in the management and treatment of diabetic patients.</div></div><div><h3>Methods</h3><div>Articles documenting unfavorable treatment outcomes and related aspects of diabetic ketoacidosis among Ethiopian diabetes patients were meticulously sought from various databases, including PubMed/MEDLINE, the Cochrane Library, Science Direct, HINARI, Google Scholar, and gray literature. After the data were extracted, they were imported into Stata software version 17 for analysis. The Cochrane Q test and I<sup>2</sup> statistic were used to evaluate heterogeneity.</div></div><div><h3>Results</h3><div>A total of 580 duplicates were eliminated from the initial set of 1578 papers obtained from PubMed (3), Google Scholar (1,550), HINARI (11), Science Direct (13), and the Cochrane Library (1). The pooled prevalence of poor treatment outcomes for diabetic ketoacidosis was 8 %. Key risk factors for poor treatment outcomes included a Glasgow Coma Scale (GCS) score of less than 15 (POR = 3.16; 95 % CI: 1.52–4.80), sepsis (POR = 2.92; 95 % CI: 1.12–4.72), and comorbidities (POR = 3.66; 95 % CI: 1.64–5.68).</div></div><div><h3>Conclusion</h3><div>The pooled prevalence of poor treatment outcomes of diabetic ketoacidosis in Ethiopia was high. A GCS score of less than 15, sepsis, and comorbidities were identified as significant risk factors for poor treatment outcomes in diabetic ketoacidosis patients. Addressing and minimizing these factors could help reduce the incidence of poor treatment outcomes in diabetic ketoacidosis patients in Ethiopia.</div></div>","PeriodicalId":94141,"journal":{"name":"Metabolism open","volume":"26 ","pages":"Article 100360"},"PeriodicalIF":2.7000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolism open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589936825000167","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Diabetic ketoacidosis is a severe complication of diabetes that can threaten life and has a considerable effect on healthcare systems, especially in developing nations such as Ethiopia. Although it is clinically significant, comprehensive data on the factors that lead to unsatisfactory treatment outcomes in diabetic ketoacidosis patients in Ethiopia are lacking. This review aims to investigate and evaluate unsatisfactory treatment outcomes and multiple contributing factors related to diabetic ketoacidosis among patients with diabetes in Ethiopia. This review seeks to identify these factors to provide insights that can guide improvements in the management and treatment of diabetic patients.

Methods

Articles documenting unfavorable treatment outcomes and related aspects of diabetic ketoacidosis among Ethiopian diabetes patients were meticulously sought from various databases, including PubMed/MEDLINE, the Cochrane Library, Science Direct, HINARI, Google Scholar, and gray literature. After the data were extracted, they were imported into Stata software version 17 for analysis. The Cochrane Q test and I2 statistic were used to evaluate heterogeneity.

Results

A total of 580 duplicates were eliminated from the initial set of 1578 papers obtained from PubMed (3), Google Scholar (1,550), HINARI (11), Science Direct (13), and the Cochrane Library (1). The pooled prevalence of poor treatment outcomes for diabetic ketoacidosis was 8 %. Key risk factors for poor treatment outcomes included a Glasgow Coma Scale (GCS) score of less than 15 (POR = 3.16; 95 % CI: 1.52–4.80), sepsis (POR = 2.92; 95 % CI: 1.12–4.72), and comorbidities (POR = 3.66; 95 % CI: 1.64–5.68).

Conclusion

The pooled prevalence of poor treatment outcomes of diabetic ketoacidosis in Ethiopia was high. A GCS score of less than 15, sepsis, and comorbidities were identified as significant risk factors for poor treatment outcomes in diabetic ketoacidosis patients. Addressing and minimizing these factors could help reduce the incidence of poor treatment outcomes in diabetic ketoacidosis patients in Ethiopia.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
埃塞俄比亚成年糖尿病患者的糖尿病酮症酸中毒治疗结果和相关因素:系统回顾和荟萃分析
糖尿病酮症酸中毒是糖尿病的一种严重并发症,可威胁生命,对医疗保健系统有相当大的影响,特别是在埃塞俄比亚等发展中国家。虽然具有临床意义,但埃塞俄比亚缺乏导致糖尿病酮症酸中毒患者治疗结果不满意的因素的综合数据。本综述旨在调查和评价埃塞俄比亚糖尿病患者不满意的治疗结果和与糖尿病酮症酸中毒相关的多种因素。本综述旨在确定这些因素,为指导糖尿病患者管理和治疗的改进提供见解。方法从PubMed/MEDLINE、Cochrane图书馆、Science Direct、HINARI、谷歌Scholar和灰色文献等数据库中仔细检索记录埃塞俄比亚糖尿病患者不良治疗结果和糖尿病酮症酸中毒相关方面的文章。数据提取后,导入Stata软件版本17进行分析。采用Cochrane Q检验和I2统计量评价异质性。结果从PubMed(3)、谷歌Scholar(1550)、HINARI(11)、Science Direct(13)和Cochrane图书馆(1)获得的1578篇论文中,共剔除了580个重复。糖尿病酮症酸中毒治疗不良的总发生率为8%。不良治疗结果的关键危险因素包括格拉斯哥昏迷评分(GCS)低于15分(POR = 3.16;95% CI: 1.52-4.80),脓毒症(POR = 2.92;95% CI: 1.12-4.72),合并症(POR = 3.66;95% ci: 1.64-5.68)。结论埃塞俄比亚糖尿病酮症酸中毒治疗不良的总发生率较高。GCS评分小于15、脓毒症和合并症被认为是糖尿病酮症酸中毒患者治疗结果不佳的重要危险因素。解决和尽量减少这些因素可能有助于减少埃塞俄比亚糖尿病酮症酸中毒患者治疗结果不佳的发生率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Metabolism open
Metabolism open Agricultural and Biological Sciences (General), Endocrinology, Endocrinology, Diabetes and Metabolism
自引率
0.00%
发文量
0
审稿时长
40 days
期刊最新文献
Investigating the causal roles of cholesterol and triglyceride subfractions across lipoproteins in irritable bowel syndrome: a Mendelian randomization study Effectiveness of a multidisciplinary “2+N system therapy” in achieving remission and metabolic improvement in type 2 diabetes: A real-world study with 1,000 patients No effect of pyrroloquinoline quinone on mouse body weight and energy metabolism with the concomitant increase in mitochondrial biogenesis and antioxidant ability Machine learning–based binary classification of elevated HbA1c (≥6.5 %) for risk assessment First European case of Geller syndrome complicated with hypokalemic nephropathy: A case report and literature review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1